Broek Richard van den

CIK: 0001431872

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PLSE

PULSE BIOSCIENCES, INC.

Director

CRVS

Corvus Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

PLSE
PULSE BIOSCIENCES, INC.
Jun 11, 2026
Award(A)
Stock Option (right to buy)
Direct
30K shares-
PLSE
PULSE BIOSCIENCES, INC.
Jun 11, 2026
Award(A)
Stock Option (right to buy)
Direct
8.4K shares-
CRVS
Corvus Pharmaceuticals, Inc.
Jun 11, 2026
Award(A)
Stock Option (Right to Buy)
Direct
15K shares-
PLSE
PULSE BIOSCIENCES, INC.
Aug 15, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
CRVS
Corvus Pharmaceuticals, Inc.
Apr 8, 2025
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-

		Type	Shares	Price		Ownership
Jun 11, 2026	PLSE PULSE BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Jun 11, 2026	PLSE PULSE BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	8,423	-	-	Direct
Jun 11, 2026	CRVS Corvus Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Buy)	15,000	-	-	Direct
Aug 15, 2025	PLSE PULSE BIOSCIENCES, INC.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Apr 8, 2025	CRVS Corvus Pharmaceuticals, Inc.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct

1-5 of 5 transactions

About van den Broek Richard

van den Broek Richard (SEC CIK 0001431872) files insider reports with the SEC as Director of PULSE BIOSCIENCES, INC. (PLSE) and Director of Corvus Pharmaceuticals, Inc. (CRVS).

Signal8 holds 5 ownership filings by van den Broek Richard (1 Form 3, 4 Form 4), filed between Apr 9, 2025 and Jun 15, 2026. Those filings report 5 transactions, from Apr 8, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on van den Broek Richard's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by van den Broek Richard

Jun 11, 2026: Grants or awards of PLSE derivative securities (2 lines, Form 4, code A).
Jun 11, 2026: Grant or award of CRVS derivative securities (Form 4, code A).
Aug 15, 2025: Grant or award of PLSE derivative securities (Form 4, code A).
Apr 8, 2025: Grant or award of CRVS derivative securities (Form 4, code A).

Other insiders filing for PULSE BIOSCIENCES, INC. (PLSE)

Teplitsky Liane Rae, Chief Operating Officer
Skinner Jon, Chief Financial Officer
Zanganeh Mahkam, Director
DUGGAN ROBERT W, Director
Soni Manmeet Singh, Director
Sainz Maria, Director

How to read Form 4 transaction codes